Virax Biolabs Group Stock Five Year Return
| VRAX Stock | USD 0.85 0.04 4.94% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Virax Biolabs' long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Virax Biolabs Group Company Five Year Return Analysis
Virax Biolabs' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Virax Biolabs Group has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Virax Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.65 | ||||
| Current Valuation | (182.12 K) | ||||
| Shares Outstanding | 4.34 M | ||||
| Shares Owned By Insiders | 10.09 % | ||||
| Shares Owned By Institutions | 6.70 % | ||||
| Number Of Shares Shorted | 23.09 K | ||||
| Price To Book | 0.64 X | ||||
| Price To Sales | 579.66 X | ||||
| Revenue | 6.33 K | ||||
| Gross Profit | (53.07 K) | ||||
| EBITDA | (5.8 M) | ||||
| Net Income | (6.07 M) | ||||
| Cash And Equivalents | 21.76 K | ||||
| Total Debt | 377 K | ||||
| Current Ratio | 0.04 X | ||||
| Book Value Per Share | 1.31 X | ||||
| Cash Flow From Operations | (4.56 M) | ||||
| Short Ratio | 0.34 X | ||||
| Earnings Per Share | (1.62) X | ||||
| Target Price | 3.0 | ||||
| Number Of Employees | 19 | ||||
| Beta | 1.64 | ||||
| Market Capitalization | 3.67 M | ||||
| Total Asset | 6.43 M | ||||
| Retained Earnings | (24.59 M) | ||||
| Working Capital | 4.22 M | ||||
| Net Asset | 6.43 M |
About Virax Biolabs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Virax Biolabs Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virax Biolabs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virax Biolabs Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Virax Stock Analysis
When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.